A. Coan

发表

Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Raghu Raghavan, April Coan, Christoph Pedain, 2010, Journal of neurosurgery.

A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma

A. Friedman, H. Friedman, D. Reardon, 2011, Journal of Neuro-Oncology.

Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.

R. Coleman, J. Herndon, E. Patz, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.

R. McLendon, A. Friedman, K. Aldape, 2011, Neuro-oncology.

Ethical Decision Making About End-of-life Care Issues by Pediatric Oncologists in Economically Diverse Settings

Christopher L Church, J. Baker, M. Hester, 2015, Journal of pediatric hematology/oncology.

Quality management of potential chemotherapy-induced neutropenic complications: evaluation of practice in an academic medical center

A. Abernethy, A. Coan, H. Uronis, 2009, Supportive Care in Cancer.

Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial

P. Douglas, L. Jones, W. Hornsby, 2014, Acta oncologica.

Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.

A. Abernethy, H. Bosworth, D. Currow, 2012, Journal of pain and symptom management.

Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

E. Lipp, H. Friedman, D. Reardon, 2012, Journal of Neuro-Oncology.

Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma

R. McLendon, H. Friedman, D. Reardon, 2012, Journal of Neuro-Oncology.

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients

A. Friedman, E. Lipp, H. Friedman, 2012, British Journal of Cancer.

Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

R. McLendon, P. Wen, A. Norden, 2011, Journal of Neuro-Oncology.

Unmet spiritual care needs impact emotional and spiritual well-being in advanced cancer patients

A. Abernethy, H. Koenig, Michelle J. Pearce, 2012, Supportive Care in Cancer.

Bevacizumab and daily temozolomide for recurrent glioblastoma

H. Friedman, D. Reardon, A. Desjardins, 2012, Cancer.

Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients

R. McLendon, A. Friedman, D. Bigner, 2015, Nature.

Informational needs assessment of non‐Hodgkin lymphoma survivors and their physicians

A. Abernethy, D. Friedman, A. Coan, 2010, American journal of hematology.

Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

R. McLendon, H. Friedman, D. Reardon, 2011, Cancer.

Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.

K. Courneya, J. Mackey, P. Douglas, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low‐grade glioma

R. McLendon, E. Lipp, H. Friedman, 2012, Cancer.

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

H. Friedman, D. Reardon, A. Desjardins, 2011, Journal of Neuro-Oncology.

A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma

R. McLendon, A. Friedman, D. Bigner, 2012, PloS one.

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

E. Lipp, H. Friedman, D. Reardon, 2013, Cancer medicine.

Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer.

A. Abernethy, L. Jones, W. Hornsby, 2012, Lung cancer.

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients

W. Hornsby, H. Friedman, A. Desjardins, 2014, Journal of Neuro-Oncology.

Use of tablet personal computers for sensitive patient-reported information.

Amy P Abernethy, Meenal Patwardhan, April Coan, 2009, The journal of supportive oncology.

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment instrument for cancer patients.

Amy P Abernethy, April Coan, Rebecca A Shelby, 2010, Journal of pain and symptom management.

Correlates of quality of life‐related outcomes in breast cancer patients participating in the Pathfinders pilot study

A. Abernethy, H. Lyerly, A. Coan, 2011, Psycho-oncology.

A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma.

John H. Sampson, Anthony F. Waller, April Coan, 2014, Journal of neurosurgery.

Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).

H. Friedman, D. Reardon, J. Kirkpatrick, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.

A. Friedman, L. Jones, W. Hornsby, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2 pilot study of Pathfinders: a psychosocial intervention for cancer patients

A. Coan, J. Wheeler, K. Rowe, 2010, Supportive Care in Cancer.